Leukemia :: Arsenic triggers unique mechanism in rare leukemia
Dartmouth Medical School researchers have identified a new way that arsenite, a form of arsenic, acts in treating a rare cancer known as APL, or acute promyelocytic leukemia. Their study is published in the Jan_3 issue of the Journal of the National Cancer Institute.